{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1360004232208822016.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1016/j.ijrobp.2010.01.065"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0360301610002683?httpAccept=text/xml"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0360301610002683?httpAccept=text/plain"}},{"identifier":{"@type":"DOI","@value":"10.1016/j.ijrobp.2009.09.010"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0360301609032039?httpAccept=text/xml"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0360301609032039?httpAccept=text/plain"}},{"identifier":{"@type":"PMID","@value":"20510192"}},{"identifier":{"@type":"PMID","@value":"20598450"}}],"resourceType":"学術雑誌論文(journal article)","dc:title":[{"@value":"Intraoperative Radiotherapy for Unresectable Pancreatic Cancer: A Multi-Institutional Retrospective Analysis of 144 Patients"}],"description":[{"notation":[{"@value":"To retrospectively analyze the results of intraoperative radiotherapy (IORT) with or without external beam radiotherapy (EBRT) for resected pancreatic cancer.The records of 210 patients treated with gross complete resection (R0: 147 patients; R1: 63 patients) and IORT with or without EBRT were reviewed. One hundred forty-seven patients (70.0%) were treated without EBRT and 114 patients (54.3%) were treated in conjunction with chemotherapy. The median doses of IORT and EBRT were 25 Gy (range, 20-30 Gy) and 45 Gy (range, 20-60Gy), respectively. The median follow-up of the surviving 62 patients was 26.3 months (range, 2.7-90.5 months).At the time of this analysis, 150 of 210 patients (71.4%) had disease recurrences. Local failure was observed in 31 patients (14.8%), and the 2-year local control rate in all patients was 83.7%. The median survival time and the 2-year actuarial overall survival (OS) in all 210 patients were 19.1 months and 42.1%, respectively. Patients treated with IORT and chemotherapy had a significantly more favorable OS than those treated with IORT alone (p = 0.0011). On univariate analysis, chemotherapy use, degree of resection, carbohydrate antigen 19-9, and pathological N stage had a significant impact on OS and on multivariate analysis; these four factors were significant prognostic factors. Late gastrointestinal morbidity of NCI-CTC Grade 4 was observed in 7 patients (3.3%).IORT yields an excellent local control rate for resected pancreatic cancer with few frequencies of severe late toxicity, and IORT combined with chemotherapy confers a survival benefit compared with that of IORT alone."}]}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1380004232208822021","@type":"Researcher","foaf:name":[{"@value":"Kazuhiko Ogawa"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004232208822020","@type":"Researcher","foaf:name":[{"@value":"Katsuyuki Karasawa"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004232208822026","@type":"Researcher","foaf:name":[{"@value":"Yoshinori Ito"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004232208822023","@type":"Researcher","foaf:name":[{"@value":"Yoshihiro Ogawa"}]},{"@id":"https://cir.nii.ac.jp/crid/1420845751135260544","@type":"Researcher","personIdentifier":[{"@type":"KAKEN_RESEARCHERS","@value":"00451592"},{"@type":"NRID","@value":"1000000451592"},{"@type":"NRID","@value":"9000001629375"},{"@type":"NRID","@value":"9000345298470"},{"@type":"NRID","@value":"9000409633816"},{"@type":"NRID","@value":"9000415073900"},{"@type":"NRID","@value":"9000411964791"},{"@type":"NRID","@value":"9000319548970"},{"@type":"NRID","@value":"9000415169758"},{"@type":"NRID","@value":"9000411963596"},{"@type":"NRID","@value":"9000408651178"},{"@type":"NRID","@value":"9000406295558"},{"@type":"NRID","@value":"9000310331376"},{"@type":"NRID","@value":"9000361678932"},{"@type":"NRID","@value":"9000238951671"},{"@type":"NRID","@value":"9000415137623"},{"@type":"NRID","@value":"9000396179310"},{"@type":"RESEARCHMAP","@value":"https://researchmap.jp/kjingu-jr"}],"foaf:name":[{"@value":"Keiichi Jingu"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004232208822017","@type":"Researcher","foaf:name":[{"@value":"Hiroshi Onishi"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004232208822019","@type":"Researcher","foaf:name":[{"@value":"Shinichi Aoki"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004232208822025","@type":"Researcher","foaf:name":[{"@value":"Hitoshi Wada"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004232208822030","@type":"Researcher","foaf:name":[{"@value":"Masaki Kokubo"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004232208822029","@type":"Researcher","foaf:name":[{"@value":"Etsuyo Ogo"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004232208822027","@type":"Researcher","foaf:name":[{"@value":"Hidehiro Etoh"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004232208822022","@type":"Researcher","foaf:name":[{"@value":"Tomoko Kazumoto"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004232208822028","@type":"Researcher","foaf:name":[{"@value":"Makoto Takayama"}]},{"@id":"https://cir.nii.ac.jp/crid/1420845751135897472","@type":"Researcher","personIdentifier":[{"@type":"KAKEN_RESEARCHERS","@value":"10208291"},{"@type":"NRID","@value":"1000010208291"},{"@type":"NRID","@value":"9000258019490"},{"@type":"NRID","@value":"9000258019295"},{"@type":"NRID","@value":"9000258019309"},{"@type":"NRID","@value":"9000258019365"},{"@type":"NRID","@value":"9000258019098"}],"foaf:name":[{"@value":"Kenji Nemoto"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004232208822018","@type":"Researcher","foaf:name":[{"@value":"Yasumasa Nishimura"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"03603016"}],"prism:publicationName":[{"@value":"International Journal of Radiation Oncology*Biology*Physics"}],"dc:publisher":[{"@value":"Elsevier BV"}],"prism:publicationDate":"2011-05","prism:volume":"80","prism:number":"1","prism:startingPage":"111","prism:endingPage":"118"},"reviewed":"false","dc:rights":["https://www.elsevier.com/tdm/userlicense/1.0/"],"url":[{"@id":"https://api.elsevier.com/content/article/PII:S0360301610002683?httpAccept=text/xml"},{"@id":"https://api.elsevier.com/content/article/PII:S0360301610002683?httpAccept=text/plain"},{"@id":"https://api.elsevier.com/content/article/PII:S0360301609032039?httpAccept=text/xml"},{"@id":"https://api.elsevier.com/content/article/PII:S0360301609032039?httpAccept=text/plain"}],"createdAt":"2011-04-09","modifiedAt":"2025-03-05","foaf:topic":[{"@id":"https://cir.nii.ac.jp/all?q=Adult","dc:title":"Adult"},{"@id":"https://cir.nii.ac.jp/all?q=Male","dc:title":"Male"},{"@id":"https://cir.nii.ac.jp/all?q=CA-19-9%20Antigen","dc:title":"CA-19-9 Antigen"},{"@id":"https://cir.nii.ac.jp/all?q=Antineoplastic%20Agents","dc:title":"Antineoplastic Agents"},{"@id":"https://cir.nii.ac.jp/all?q=Intraoperative%20Period","dc:title":"Intraoperative Period"},{"@id":"https://cir.nii.ac.jp/all?q=Japan","dc:title":"Japan"},{"@id":"https://cir.nii.ac.jp/all?q=Humans","dc:title":"Humans"},{"@id":"https://cir.nii.ac.jp/all?q=Radiation%20Injuries","dc:title":"Radiation Injuries"},{"@id":"https://cir.nii.ac.jp/all?q=Aged","dc:title":"Aged"},{"@id":"https://cir.nii.ac.jp/all?q=Neoplasm%20Staging","dc:title":"Neoplasm Staging"},{"@id":"https://cir.nii.ac.jp/all?q=Retrospective%20Studies","dc:title":"Retrospective Studies"},{"@id":"https://cir.nii.ac.jp/all?q=Aged,%2080%20and%20over","dc:title":"Aged, 80 and over"},{"@id":"https://cir.nii.ac.jp/all?q=Analysis%20of%20Variance","dc:title":"Analysis of Variance"},{"@id":"https://cir.nii.ac.jp/all?q=Intraoperative%20Care","dc:title":"Intraoperative Care"},{"@id":"https://cir.nii.ac.jp/all?q=Radiotherapy%20Dosage","dc:title":"Radiotherapy Dosage"},{"@id":"https://cir.nii.ac.jp/all?q=Middle%20Aged","dc:title":"Middle Aged"},{"@id":"https://cir.nii.ac.jp/all?q=Survival%20Analysis","dc:title":"Survival Analysis"},{"@id":"https://cir.nii.ac.jp/all?q=Combined%20Modality%20Therapy","dc:title":"Combined Modality Therapy"},{"@id":"https://cir.nii.ac.jp/all?q=Tumor%20Burden","dc:title":"Tumor Burden"},{"@id":"https://cir.nii.ac.jp/all?q=Pancreatic%20Neoplasms","dc:title":"Pancreatic Neoplasms"},{"@id":"https://cir.nii.ac.jp/all?q=Female","dc:title":"Female"},{"@id":"https://cir.nii.ac.jp/all?q=Neoplasm%20Recurrence,%20Local","dc:title":"Neoplasm Recurrence, Local"}],"project":[{"@id":"https://cir.nii.ac.jp/crid/1040000782168379136","@type":"Project","projectIdentifier":[{"@type":"KAKEN","@value":"23591831"},{"@type":"JGN","@value":"JP23591831"},{"@type":"URI","@value":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-23591831/"}],"notation":[{"@language":"ja","@value":"新しいバイオマーカーを用いた食道癌照射野の個別化"},{"@language":"en","@value":"Relationship between biomarker expression and lymph node metastasis in esophageal cancer: searching for an optimal radiation field"}]}],"relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360011143901216512","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Intraoperative radiotherapy in carcinoma of the stomach and pancreas"}]},{"@id":"https://cir.nii.ac.jp/crid/1360011144899571712","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Systematic review, including meta-analyses, on the management of locally advanced pancreatic cancer using radiation/combined modality therapy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360011145763206272","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Normal tissue tolerance to intraoperative radiotherapy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360292621268471808","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Nonparametric Estimation from Incomplete Observations"}]},{"@id":"https://cir.nii.ac.jp/crid/1360565165920388096","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Concurrent Radiotherapy and Gemcitabine for Unresectable Pancreatic Adenocarcinoma: Impact of Adjuvant Chemotherapy on Survival"}]},{"@id":"https://cir.nii.ac.jp/crid/1360574093989129216","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Intraoperative and external beam irradiation ± 5-FU for locally advanced pancreatic cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848656166879104","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"An autopsy study to clarify characteristics of local recurrence after extended pancreatectomy with intraoperative radiation therapy in patients with pancreatic cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1360855570140572800","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"The role of misonidazole combined with intraoperative radiation therapy in the treatment of pancreatic carcinoma."}]},{"@id":"https://cir.nii.ac.jp/crid/1360855571353255168","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Cancer of the pancreas: 50 years of surgery"}]},{"@id":"https://cir.nii.ac.jp/crid/1361137045169085184","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Intensity-modulated radiotherapy (IMRT) and concurrent capecitabine for pancreatic cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1361137045849528064","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Intraoperative radiation therapy of pancreatic carcinoma: A report of RTOG-8505"}]},{"@id":"https://cir.nii.ac.jp/crid/1361137045856462464","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Combined intraoperative radiation and perioperative chemotherapy for unresectable cancers of the pancreas."}]},{"@id":"https://cir.nii.ac.jp/crid/1361137045944911744","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"External beam versus intraoperative and external beam irradiation for locally advanced pancreatic cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1361418519874519936","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Patterns of Radiotherapy Practice for Pancreatic Cancer in Japan: Results of the Japanese Radiation Oncology Study Group (JROSG) Survey"}]},{"@id":"https://cir.nii.ac.jp/crid/1361699994022050432","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"5 FU infusion with mitomycin-C vs. 5 FU infusion with methyl-CCNU in the treatment of advanced upper gastrointestinal cancer. A Southwest oncology group study"}]},{"@id":"https://cir.nii.ac.jp/crid/1361699994208632320","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Therapy of locally unresectable pancreatic carcinoma: A randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil. The gastrointestinal tumor study group"}]},{"@id":"https://cir.nii.ac.jp/crid/1361699994809555456","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Cancer Statistics, 2008"}]},{"@id":"https://cir.nii.ac.jp/crid/1361981468760804608","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Stereotactic radiotherapy for unresectable adenocarcinoma of the pancreas"}]},{"@id":"https://cir.nii.ac.jp/crid/1361981470866359680","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Effect of intraoperative radiotherapy combined with external beam radiotherapy following internal drainage for advanced pancreatic carcinoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1361981470866584960","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Intraoperative radiotherapy in pancreatic cancer: A systematic review"}]},{"@id":"https://cir.nii.ac.jp/crid/1361981471459405568","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"External and intraoperative radiotherapy for resectable and unresectable pancreatic cancer: Analysis of survival rates and complications"}]},{"@id":"https://cir.nii.ac.jp/crid/1362262944695175936","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"High-dose intraoperative radiotherapy for unresectable pancreatic cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1362262944871154944","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"High dose, external beam and intraoperative radiotherapy in the treatment of resectable and unresectable pancreatic cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1362262946232203264","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"A phase I trial of S-1 with concurrent radiotherapy for locally advanced pancreatic cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1362544419567313792","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Intraoperative Electron Beam Irradiation for Patients with Unresectable Pancreatic Carcinoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1362544420460018048","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Intraoperative irradiation for unresectable pancreatic carcinoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1362544420814994688","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Intraoperative and conformal external‐beam radiation therapy with protracted 5‐fluorouracil infusion in patients with locally advanced pancreatic carcinoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1362825893630845312","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Mitomycin C Therapy in Advanced Gastrointestinal Cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1362825896384814848","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Radiotherapy of unresectable pancreatic carcinoma: A six year experience with 104 patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1363107371100146432","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial."}]},{"@id":"https://cir.nii.ac.jp/crid/1363388843680236416","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Clinical Experience With Regional Pancreatectomy for Adenocarcinoma of the Pancreas"}]},{"@id":"https://cir.nii.ac.jp/crid/1363388844186067456","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Efficacy of novel hypoxic cell sensitiser doranidazole in the treatment of locally advanced pancreatic cancer: Long-term results of a placebo-controlled randomised study"}]},{"@id":"https://cir.nii.ac.jp/crid/1363388845849787776","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Resection versus Palliation: Treatment of Stage III and IVA Carcinomas of the Pancreas Employing Intraoperative Radiation"}]},{"@id":"https://cir.nii.ac.jp/crid/1363951794872935424","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"A phase I study of combined UFT plus leucovorin and radiotherapy for pancreatic cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1364233269432145152","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Electron beam intraoperative radiation therapy (EBIORT) for localized pancreatic carcinoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1364233269636459136","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Regression Models and Life-Tables"}]},{"@id":"https://cir.nii.ac.jp/crid/1370006919255025676","@type":"Product","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Evaluation of survival data and two new rank order statistics arising in its consideration"}]},{"@id":"https://cir.nii.ac.jp/crid/1370006919255025798","@type":"Product","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Intraoperative radiotherapy and bypass surgery for unresectable pancreatic cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1370006919255025802","@type":"Product","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Cancer of the pancreas"}]},{"@id":"https://cir.nii.ac.jp/crid/1390295027678827008","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Clinical Outcomes of Intraoperative Radiotherapy, Postoperative Radiotherapy, and Definitive Radiotherapy for Non-metastatic Pancreatic Cancer"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1016/j.ijrobp.2010.01.065"},{"@type":"CROSSREF","@value":"10.1016/j.ijrobp.2009.09.010"},{"@type":"KAKEN","@value":"PRODUCT-14175240"},{"@type":"OPENAIRE","@value":"doi_dedup___::1802c28633b55778178c7dbdf0c9edfb"},{"@type":"CROSSREF","@value":"10.1016/j.ijrobp.2010.01.065_references_DOI_ZZtan3RjZxWK8nX1HzWwdmClLKZ"},{"@type":"CROSSREF","@value":"10.2739/kurumemedj.ms674002_references_DOI_ZZtan3RjZxWK8nX1HzWwdmClLKZ"},{"@type":"CROSSREF","@value":"10.1007/s00423-012-0934-8_references_DOI_ZZtan3RjZxWK8nX1HzWwdmClLKZ"},{"@type":"CROSSREF","@value":"10.1016/j.ijrobp.2011.07.013_references_DOI_6U1I7un3srFoTF78HEDkrn4cXks"},{"@type":"CROSSREF","@value":"10.1016/j.ijrobp.2011.07.013_references_DOI_ZZtan3RjZxWK8nX1HzWwdmClLKZ"}]}